1149 related articles for article (PubMed ID: 30429608)
1. Sensitive tumour detection and classification using plasma cell-free DNA methylomes.
Shen SY; Singhania R; Fehringer G; Chakravarthy A; Roehrl MHA; Chadwick D; Zuzarte PC; Borgida A; Wang TT; Li T; Kis O; Zhao Z; Spreafico A; Medina TDS; Wang Y; Roulois D; Ettayebi I; Chen Z; Chow S; Murphy T; Arruda A; O'Kane GM; Liu J; Mansour M; McPherson JD; O'Brien C; Leighl N; Bedard PL; Fleshner N; Liu G; Minden MD; Gallinger S; Goldenberg A; Pugh TJ; Hoffman MM; Bratman SV; Hung RJ; De Carvalho DD
Nature; 2018 Nov; 563(7732):579-583. PubMed ID: 30429608
[TBL] [Abstract][Full Text] [Related]
2. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
3. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
4. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
5. An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.
Ono Y; Sugitani A; Karasaki H; Ogata M; Nozaki R; Sasajima J; Yokochi T; Asahara S; Koizumi K; Ando K; Hironaka K; Daito T; Mizukami Y
Mol Oncol; 2017 Oct; 11(10):1448-1458. PubMed ID: 28691390
[TBL] [Abstract][Full Text] [Related]
6. Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification.
Liu L; Toung JM; Jassowicz AF; Vijayaraghavan R; Kang H; Zhang R; Kruglyak KM; Huang HJ; Hinoue T; Shen H; Salathia NS; Hong DS; Naing A; Subbiah V; Piha-Paul SA; Bibikova M; Granger G; Barnes B; Shen R; Gutekunst K; Fu S; Tsimberidou AM; Lu C; Eng C; Moulder SL; Kopetz ES; Amaria RN; Meric-Bernstam F; Laird PW; Fan JB; Janku F
Ann Oncol; 2018 Jun; 29(6):1445-1453. PubMed ID: 29635542
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
Gai W; Sun K
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
[TBL] [Abstract][Full Text] [Related]
8. Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer.
Vietsch EE; Graham GT; McCutcheon JN; Javaid A; Giaccone G; Marshall JL; Wellstein A
Cancer Genet; 2017 Dec; 218-219():39-50. PubMed ID: 29153095
[TBL] [Abstract][Full Text] [Related]
9. A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
Shinjo K; Hara K; Nagae G; Umeda T; Katsushima K; Suzuki M; Murofushi Y; Umezu Y; Takeuchi I; Takahashi S; Okuno Y; Matsuo K; Ito H; Tajima S; Aburatani H; Yamao K; Kondo Y
PLoS One; 2020; 15(6):e0233782. PubMed ID: 32520974
[TBL] [Abstract][Full Text] [Related]
10. Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients.
Palande V; Raviv Shay D; Frenkel-Morgenstern M
J Vis Exp; 2020 Sep; (163):. PubMed ID: 32986022
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
Zeng H; He B; Yi C; Peng J
J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients.
Gao P; Lin S; Cai M; Zhu Y; Song Y; Sui Y; Lin J; Liu J; Lu X; Zhong Y; Cui Y; Zhou P
J Cell Mol Med; 2019 May; 23(5):3530-3537. PubMed ID: 30912288
[TBL] [Abstract][Full Text] [Related]
13. Reviews on Current Liquid Biopsy for Detection and Management of Pancreatic Cancers.
Kaczor-Urbanowicz KE; Cheng J; King JC; Sedarat A; Pandol SJ; Farrell JJ; Wong DTW; Kim Y
Pancreas; 2020 Oct; 49(9):1141-1152. PubMed ID: 33003085
[TBL] [Abstract][Full Text] [Related]
14. Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization.
Nguyen VTC; Nguyen TH; Doan NNT; Pham TMQ; Nguyen GTH; Nguyen TD; Tran TTT; Vo DL; Phan TH; Jasmine TX; Nguyen VC; Nguyen HT; Nguyen TV; Nguyen THH; Huynh LAK; Tran TH; Dang QT; Doan TN; Tran AM; Nguyen VH; Nguyen VTA; Ho LMQ; Tran QD; Pham TTT; Ho TD; Nguyen BT; Nguyen TNV; Nguyen TD; Phu DTB; Phan BHH; Vo TL; Nai THT; Tran TT; Truong MH; Tran NC; Le TK; Tran THT; Duong ML; Bach HPT; Kim VV; Pham TA; Tran DH; Le TNA; Pham TVN; Le MT; Vo DH; Tran TMT; Nguyen MN; Van TTV; Nguyen AN; Tran TT; Tran VU; Le MP; Do TT; Phan TV; Nguyen HL; Nguyen DS; Cao VT; Do TT; Truong DK; Tang HS; Giang H; Nguyen HN; Phan MD; Tran LS
Elife; 2023 Oct; 12():. PubMed ID: 37819044
[TBL] [Abstract][Full Text] [Related]
15. [What future for circulating tumor DNA? Current data and prospects in colorectal, non-small cell lung and pancreatic cancers].
Pietrasz D; Pécuchet N; Fabre E; Blons H; Chevalier L; Taly V; Laurent-Puig P; Bachet JB
Bull Cancer; 2016 Jan; 103(1):55-65. PubMed ID: 26790710
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Power of DNA Methylation Classifiers for Early Detection of Cancer.
Roy D; Tiirikainen M
Trends Cancer; 2020 Feb; 6(2):78-81. PubMed ID: 32061307
[TBL] [Abstract][Full Text] [Related]
17. Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA.
van der Pol Y; Mouliere F
Cancer Cell; 2019 Oct; 36(4):350-368. PubMed ID: 31614115
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
[TBL] [Abstract][Full Text] [Related]
19. Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer.
Cao F; Wei A; Hu X; He Y; Zhang J; Xia L; Tu K; Yuan J; Guo Z; Liu H; Xie D; Li A
Clin Epigenetics; 2020 Jul; 12(1):112. PubMed ID: 32703318
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood.
Eissa MAL; Lerner L; Abdelfatah E; Shankar N; Canner JK; Hasan NM; Yaghoobi V; Huang B; Kerner Z; Takaesu F; Wolfgang C; Kwak R; Ruiz M; Tam M; Pisanic TR; Iacobuzio-Donahue CA; Hruban RH; He J; Wang TH; Wood LD; Sharma A; Ahuja N
Clin Epigenetics; 2019 Apr; 11(1):59. PubMed ID: 30953539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]